Landgren Breaks Down the Benefit of Novel Quadruplet in Newly Diagnosed Myeloma

May 31, 06:50 PM

Dr. Landgren discusses the potential of a quadruplet regimen comprised of carfilzomib, lenalidomide, dexamethasone, and daratumumab in the treatment of patients with newly diagnosed multiple myeloma.